Skip to main content
. 2020 Jul 16;10(7):1059. doi: 10.3390/biom10071059

Table 6.

The prognostic value of the expression of up- and downregulated miRNAs in breast cancer patients stratified by estrogen receptor (ER) and human epidermal growth factor receptor 2 (Her2) expression status.

miRNA ER Her2
Positive (n = 979) Negative (n = 283) Positive (n = 157) Negative (n = 1105)
HR 95%
CI
p
Value
HR 95%
CI
p
Value
HR 95% CI p Value HR 95% CI p
Value
Upregulated let-7b-5p 0.72
(0.56–0.92)
0.0083 1.38
(0.94–2.02)
0.096 0.56
(0.35–0.91)
0.018 0.75
(0.6–0.93)
0.01
miR-100-5p 0.65
(0.52–0.8)
0.00025 0.78
(0.52–1.19)
0.25 0.53
(0.32–0.87)
0.011 0.7
(0.57–0.88)
0.0015
miR-140-5p 0.66
(0.53–0.84)
0.00048 0.67
(0.46–0.98)
0.039 0.68
(0.4–1.14)
0.14 0.67
(0.54–0.84)
0.00043
miR-181b-5p 1.56
(1.21–2.01)
0.00046 1.45
(0.97–2.16)
0.066 0.76
(0.45–1.15)
0.16 1.48
(1.17–1.86)
0.00092
miR-181c-5p 0.57
(0.45–0.72)
2.5 × 10−06 1.24
(0.85–1.82)
0.26 0.68
(0.42–1.11)
0.12 0.66
(0.53–0.82)
0.00014
miR-181d-5p 0.7
(0.55–0.88)
0.0022 1.78
(1.09–2.92)
0.02 0.63
(0.46–0.86)
0.0039 0.77
(0.62–0.95)
0.015
miR-199a-3p 0.66
(0.51–0.84)
0.00067 1.29
(0.85–1.94)
0.23 1.3
(0.81–2.08)
0.28 0.66
(0.53–0.82)
0.00014
miR-222-3p 1.44
(1.09–1.91)
0.011 1.35
(0.93–1.96)
0.11 1.55
(0.96–2.51)
0.073 1.38
(1.06–1.79)
0.016
miR-328-3p 0.76
(0.57–1.02)
0.065 0.69
(0.45–1.07)
0.098 0.6
(0.37–0.98)
0.039 0.8
(0.64–1.01)
0.056
miR-495-3p 0.66
(0.52–0.84)
0.00079 0.84
(0.58–1.21)
0.35 0.68
(0.42–1.09)
0.11 0.66
(0.53–0.84)
0.00043
Downregulated miR-1-3p 0.64
(0.49–0.85)
0.0015 0.73
(0.46–1.16)
0.18 0.62
(0.38–1.02)
0.059 0.64
(0.49–0.83)
0.00077
miR-107 1.24
(0.97–1.58)
0.091 0.79
(0.52–1.19)
0.25 0.75
(0.47–1.22)
0.25 1.22
(0.97–1.54)
0.092
miR-129-5p 1.45
(1.13–1.86)
0.0037 0.83
(0.56–1.25)
0.37 0.68
(0.41–1.14)
0.14 1.36
(1.07–1.71)
0.011
miR-141-3p 1.53
(1.21–1.93)
0.00029 1.47
(1–2.17)
0.049 1.63
(0.98–2.69)
0.055 1.45
(1.17–1.8)
0.00071
miR-145-5p 0.81
(0.63–1.03)
0.084 1.15
(0.79–1.68)
0.45 1.32
(0.78–2.22)
0.3 0.79
(0.63–0.98)
0.033
miR-148a-3p 0.61
(0.48–0.78)
4.3 × 10−05 1.51
(0.98–2.31)
0.058 0.72
(0.43–1.2)
0.2 0.65
(0.52–0.82)
0.00028
miR-15b-5p 1.26
(0.98–1.62)
0.075 0.82
(0.54–1.24)
0.34 0.64
(0.4–1.04)
0.067 1.3
(1.04–1.64)
0.024
miR-182-5p 0.87
(0.67-1.13)
0.31 1.48
(1–2.19)
0.049 0.62
(0.37–0.96)
0.033 0.84
(0.65–1.08)
0.18
miR-200b-3p 0.9
(0.71–1.13)
0.36 1.72
(1.12–2.66)
0.013 1.4
(0.83–2.36)
0.2 1.15
(0.91–1.46)
0.25
miR-200c-3p 1.5
(1.18–1.9)
0.00083 1.49
(1.01–2.2)
0.045 1.48
(0.92–2.4)
0.1 1.53
(1.21–1.92)
0.00028
miR-203a-3p NO DATA FOUND
miR-205-5p 0.66
(0.52–0.84)
0.00055 1.4
(0.94–2.07)
0.094 1.47
(0.89–2.44)
0.13 0.72
(0.58–0.9)
0.0036
miR-206-5p 1.31
(1–1.71)
0.051 1.3
(0.84–2)
0.23 1.36
(0.85–2.19)
0.2 1.34
(1.04–1.72)
0.022
miR-20b-5p 0.8
(0.61–1.05)
0.11 1.17
(0.8–1.71)
0.41 1.46
(0.89–2.38)
0.13 1.11
(0.87–1.41)
0.42
miR-210-3p 1.62
(1.26–2.09)
0.00014 1.97
(1.36–2.85)
0.00025 1.39
(0.86–2.26)
0.18 1.6
(1.26–2.02)
9.3 × 10−05
miR-29b-3p 0.66
(0.52–0.85)
0.00091 0.63
(0.43–0.91)
0.014 1.26
(0.76–2.09)
0.37 0.6
(0.47–0.76)
2.1 × 10−05
miR-485-5p 0.62
(0.48–0.8)
0.00015 1.19
(0.78–1.84)
0.42 0.77
(0.47–1.28)
0.32 0.61
(0.49–0.76)
1.2 × 10−05
miR-96-5p 0.75
(0.59–0.96)
0.02 1.2
(0.79–1.81)
0.39 0.6
(0.37–0.98)
0.038 0.76
(0.61–0.95)
0.018

Log-rank p-values and hazard ratios (HRs; 95 % confidence interval in parentheses) are shown. Bold typing of p-values indicates a significant association (p < 0.05). Black typing is associated with better overall survival, while red typing is associated with worse overall survival. Gene chip data were used for this analysis.